Last update 01 Nov 2024
Vicore Pharma AB

Vicore Pharma AB

Public Company | Subsidiary Company|
2009|
Sweden
|
10-50
| STO: VICO|

Overview

Basic Info

Introduction
Vicore Pharma is a pharmaceutical corporation that focuses on creating groundbreaking medications for severe lung conditions. Their drug candidates function by interacting with the AT2 receptor. One of their leading drug candidates, C21, aims to enhance the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug status in both the EU and the US. C21 is also being researched pre-clinically for other rare diseases where the AT2 receptor is crucial.

Tags

Respiratory Diseases
Other Diseases
Endocrinology and Metabolic Disease
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug4

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Phase 1 Clinical
Phase 2 Clinical
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Buloxibutid
( AT2R )
Idiopathic Pulmonary Fibrosis
More
Phase 2
C-106
( AT2R )
Idiopathic Pulmonary Fibrosis
More
Phase 1
C-112
( ACE )
-
Preclinical
C-111
( ACE )
-
Preclinical
VP04 (Vicore Pharma)
Pulmonary Fibrosis
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free